NCT00213109CompletedPhase 3
Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Locations
- 7
Study Overview
Brief Summary
The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type1 Diabetes Mellitus treated with insulin.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Type1 Diabetes
- •Criteria of postprandial glucose and HbA1c are met
Exclusion Criteria
- •Type2 Diabetes
- •Patients with antidiabetic drugs
- •The other exclusion criteria are met
Investigators
Study Sites (7)
Loading locations...
Similar Trials
Completed
Phase 3
Open Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideType 2 Diabetes MellitusNCT00334503Sanwa Kagaku Kenkyusho Co., Ltd.
Completed
Phase 3
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideType 2 Diabetes MellitusNCT00334399Sanwa Kagaku Kenkyusho Co., Ltd.
Completed
Phase 3
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin TreatmentType 2 Diabetes MellitusNCT00213070Sanwa Kagaku Kenkyusho Co., Ltd.
Active, not recruiting
Phase 1
Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study ProtocolDiabetes Mellitus, Type 1NCT02402439Andrew Posselt3
Active, not recruiting
Phase 1
A Study of DM001 in Patients With Advanced Solid TumorsBreast NeoplasmsCarcinoma, Non-Small-Cell LungSolid CarcinomaNCT06475937Xadcera Biopharmaceutical (Suzhou) Co., Ltd.128